CHITOSE will exhibit its Cell Line Development (CLD) Platform at the upcoming INTERPHEX WEEKTokyo 2026 at Makuhari Messe from May 20th to 22nd. Demonstrating the capability to produce over 10 g/L of antibody within a 5-day cultivation period, this CLD platform, using high-performance CHO-MK cells, is designed to improve productivity and significantly reduce the cost of goods (CoG).

Our biopharmaceutical manufacturing team will welcome you at our booth (#11-31) to discuss how our technologies can accelerate your manufacturing timeline. 

We look forward to connecting with you!

Contact: biologics.contact◎chitose-bio.com
*replace ◎ with @

Event Overview
Event Name: INTERPHEX Week Tokyo 2026
Date and Time: Wednesday, May 20th – Friday, May 22nd, 2026
Venue: Makuhari Messe (Chiba, Japan)
CHITOSE booth: No.11-31

CHITOSE Stable Cell Line Development Service
https://chitose-bio.com/cld-service
Through over 10 years of research, CHITOSE has developed the highly productive CHO-MK host cell line and designed the original Chitose Super CHO expression system (CS CHO). With the combination of these innovations, we have established an extremely robust and flexible system to address the needs for a faster and more cost-effective cell line-based protein expression platform.

Related Information
[Press Release] The University of Tokyo and Chitose Laboratory Drive New Development in Digital Design for Manufacturing Process of Antibody Drugs
[Press Release] CHITOSE and FUJIFILM Biosciences Form Strategic Alliance to Drive Global Innovation and Biopharmaceutical Manufacturing
[News] Paper on Novel CHO-MK Cell Line Receives 2025 Excellent Paper Award from the Society of Biotechnology, Japan
[Press Release] High-Performance Novel HAT Cell Line for Gene Therapy, Published in Molecular Therapy Methods & Clinical Development, and Ready for Commercial Use